Twilight Zone stuff to be clear. Among others, I got my business partner to invest at what (I thought was) an insanely attractive entry ($.50). He doesn’t follow it nearly as closely (because he’s smart) and I send him these PRs. And he’s always like “that’s great - is this going to help me get back to $.50?” He’s mostly joking, but it made me think that a 50% move only gets us to the high .40s.
The SP has been more than cut in half over the period of adding cancer, Prep, and multiple Other massive scientific breakthroughs. I get that this is a function of raising money, etc, but I don’t see how we’re even close to managing the insane value of this product. Feels more that it’s being under managed in a big way.
At this point I’m excited for people that can get helped by new trials, but as an investor, I assign zero expectation of a SP move on anything other than curing our financial woes (even if they discover that Leronlimab cures aging).
We also need to get off of this dogsh#*! exchange.